Showing results (121-130 of 672) with videos related to
Sort By:
Pageof 68
Biochimica Et Biophysica Acta|November 8, 2011
Roles of PPARs in NAFLD: potential therapeutic targetsAnne Tailleux, Kristiaan Wouters, Bart StaelsTrends in Endocrinology and Metabolism: TEM|April 20, 2012
Thiazolidinediones and PPARγ agonists: time for a reassessmentBertrand Cariou, Bernard Charbonnel, Bart StaelsMolecular and Cellular Biology|March 27, 2013
Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytesSandrine Caron, Carolina Huaman Samanez, Hélène Dehondt, et al.Hepatology (Baltimore, Md.)|May 13, 2020
Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)Jimmy Vandel, Julie Dubois-Chevalier, Céline Gheeraert, et al.Atherosclerosis|February 28, 2020
Nuclear receptors in abdominal aortic aneurysmsJaap G Neels, Réda Hassen-Khodja, Giulia ChinettiInternational Journal of Cardiology|April 29, 2015
Structural and functional changes in HDL with low grade and chronic inflammationFrancis O'Neill, Meliana Riwanto, Marietta Charakida, et al.Blood|June 4, 2011
p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophagesCéline Cudejko, Kristiaan Wouters, Lucía Fuentes, et al.The Journal of Biological Chemistry|April 19, 2012
Human adipose tissue macrophages display activation of cancer-related pathwaysThérèse Hérvée Mayi, Mehdi Daoudi, Bruno Derudas, et al.International Journal of Cardiology|January 25, 2014
HDL does not influence the polarization of human monocytes toward an alternative phenotypeSophie Colin, Mélanie Fanchon, Loic Belloy, et al.Journal of Biological Methods|August 28, 2019
Development and implementation of a cell-based assay to discover agonists of the nuclear receptor REV-ERBαYuliya Hering, Alexandre Berthier, Helene Duez, et al.Pageof 68